Aantal gebruikers 2019-2023 voor ATC-subgroep J05AF : Nucleoside en nucleotide reverse-transcriptaseremmers
- Raming voor de totale Zvw-populatie
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| J05AF01 Zidovudine (Retrovir ®) | 26 | 14 | 19 | 25 | 13 |
| J05AF05 Lamivudine (Epivir ®) | 768 | 565 | 474 | 441 | 360 |
| J05AF06 Abacavir (Ziagen ®) | 234 | 184 | 151 | 121 | 101 |
| J05AF07 Tenofovirdisoproxil (Viread ®) | 2.245 | 2.187 | 2.168 | 2.241 | 2.268 |
| J05AF08 Adefovir | 71 | 51 | 43 | 33 | 24 |
| J05AF09 Emtricitabine (Emtriva ®) | 34 | 34 | 35 | 34 | 33 |
| J05AF10 Entecavir (Baraclude ®) | 2.052 | 2.078 | 2.176 | 2.278 | 2.483 |
| J05AF11 Telbivudine | 7 | 2 | . | . | . |
| J05AF13 Tenofoviralafenamide (Vemlidy ®) | 414 | 527 | 564 | 636 | 724 |